<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Allergy]]></title>
    <link>https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/pharmaceuticals/therapeutic-areas/allergy</link>
    <description><![CDATA[Allergy]]></description>
    <pubDate>Fri, 10 Apr 2026 06:02:21 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Allergy Diagnostics - Market Insights, Competitive Landscape and Market Forecast–2027]]></title>
      <link>https://www.leadingmarketresearch.com/allergy-diagnostics</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Allergy Diagnostics Market By Type (Products [Instruments And Consumables], And Services), By Allergy Type (Food Allergy, Drug Allergy, Inhalant Alllergy, And Others), By Diagnostic Test Type (In-Vivo And In-Vitro), By End User (Hospitals, Diagnostic Centers, And Others), by geography, is expected to grow at a significant CAGR forecast till 2026 due to the increasing incidence of various allergies such as food allergy and drug allergy as well as growing focus on developing innovative allergy diagnostic products

The global allergy diagnositcs market was valued at USD 4.58 billion in 2020, growing at a CAGR of 11.78% during the forecast period from 2021 to 2026, to reach USD 8.93 billion by 2026. The allergy diagnostics market is gaining momentum owing to the rapidly rising incidence of allergic diseases. Moreover, increasing environmental pollution such as decreasing air quality in industrialized areas due to increasing air pollution is also a factor propelling the allergy diagnostics market. In addition, the technological advancements and the launch of new allergy diangostic tests...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-229319"><span class="price">$2,750.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 27 Jul 2023 13:11:23 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cat Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update]]></title>
      <link>https://www.leadingmarketresearch.com/cat-allergy-drugs-in-development-by-stages-target-moa-roa-molecule-type</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Cat Allergy - Drugs In Development, 2022, provides an overview of the Cat Allergy (Immunology) pipeline landscape.<br><br>Cat allergy is an allergic reaction to one or more allergens produced by cats. Symptoms include sneezing, runny or stuffy nose, facial pain (from nasal congestion), coughing, chest tightness, shortness of breath and wheezing, watery, red or itchy eyes and skin rash or hives. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Cat Allergy - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Cat Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.<br><br>The Cat Allergy (Immunolog...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-226173"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 03 Jun 2022 13:17:15 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update]]></title>
      <link>https://www.leadingmarketresearch.com/grass-pollen-allergy-drugs-in-development-by-stages-target-moa-roa-mole</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Grass Pollen Allergy - Drugs In Development, 2022, provides an overview of the Grass Pollen Allergy (Immunology) pipeline landscape.<br><br>Grass pollen allergy is a reaction which occurs soon after exposure to pollen from grasses. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, tightening of the throat, shortness of breath or wheezing and runny nose. Predisposing factors include age, family history and other allergies. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Grass Pollen Allergy - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Grass Pollen Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-226174"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 03 Jun 2022 13:17:15 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[House Dust Mite Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update]]></title>
      <link>https://www.leadingmarketresearch.com/house-dust-mite-allergy-drugs-in-development-by-stages-target-moa-roa-m</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the House Dust Mite Allergy (Immunology) pipeline landscape.<br><br>House dust mite allergy is an allergic reaction to tiny bugs that commonly live in house dust. Symptoms include frequent sneezing, a runny, stuffy, itchy nose and irritated eyes. Asthma and eczema can also be triggered by a dust mite allergy. Symptoms often worsen when the individual comes in close proximity to disturbed dust. The predisposing factors include family history and age. Treatment includes antihistamines, decongestants and corticosteroids. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide House Dust Mite Allergy - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics under development for House D...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-222266"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 08 Apr 2022 11:35:28 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Birch Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update]]></title>
      <link>https://www.leadingmarketresearch.com/birch-pollen-allergy-drugs-in-development-by-stages-target-moa-roa-mole</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Birch Pollen Allergy - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Birch Pollen Allergy (Immunology) pipeline landscape.<br><br>Birch pollen allergy is a reaction which occurs soon after exposure to pollen of birch trees. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching, or tingling in or around the mouth and throat, digestive problems, such as diarrhea, stomach cramps, nausea or vomiting, tightening of the throat, shortness of breath or wheezing and runny nose. Predisposing factors include age, family history and other allergies. Treatment includes drugs belonging to class of antihistamines. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Birch Pollen Allergy - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on t...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-222267"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 08 Apr 2022 11:35:28 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Global Allergic Rhinitis Immunotherapy Market Research Report 2021-2025]]></title>
      <link>https://www.leadingmarketresearch.com/global-allergic-rhinitis-immunotherapy-market-research-report-2021-2025</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">Allergic rhinitis (AR) is a common, IgE-mediated inflammatory disease in which an individual reacts to an otherwise innocuous inhaled substance in the environment with one or more of the following symptoms: rhinorrhea, sneezing, nasal congestion, and pruritus of the eyes, nose, and palate. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Allergic Rhinitis Immunotherapy Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).

In this report, the global Allergic Rhinitis Immunotherapy market is valued at USD XX million in 2021 and is projected to reach USD XX million by the end of 2025, growing at a CAGR of XX% during the period 2021 to 2025.

The report firstly introduced the Allergic Rhinitis Immunotherapy basics: definiti...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-220795"><span class="price">$3,200.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 08 Sep 2021 15:45:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Allergy Drugs Markets in China]]></title>
      <link>https://www.leadingmarketresearch.com/allergy-drugs-markets-in-china</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">China&#039;s demand for  Allergy Drugs  has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China&#039;s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2010, 2015 and 2020) and long-term forecasts through 2025 and 2030 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-218513"><span class="price">$4,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 12 May 2021 15:00:05 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Allergy Drugs Industry Forecasts - China Focus]]></title>
      <link>https://www.leadingmarketresearch.com/allergy-drugs-industry-forecasts-china-focus</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">This study focuses on China’s Allergy Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace.   The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services.  The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market. 

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation a...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-218564"><span class="price">$1,800.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 12 May 2021 15:00:05 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Allergy Drugs Companies in China]]></title>
      <link>https://www.leadingmarketresearch.com/allergy-drugs-companies-in-china</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">This study focuses on China’s Allergy Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace.   The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services.  The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market. 

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering fr...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-218615"><span class="price">$1,800.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 12 May 2021 15:00:05 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Peanut Allergy – Pipeline Insight, 2020]]></title>
      <link>https://www.leadingmarketresearch.com/peanut-allergy-pipeline-insight-2020</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;">DelveInsight’s, “Peanut Allergy – Pipeline Insight, 2020,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Peanut Allergy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.  
Geography Covered
• Global coverage
Peanut Allergy Understanding
Peanut Allergy: Overview
A peanut allergy is a reaction that occurs when body mistakenly identifies peanuts as harmful substances. When you eat peanuts or food containing peanuts, your immune system —the body&#039;s natural defense system that fights infections and diseases—overreacts and can cause a serious, even life-threatening response.
Symptoms 
The most severe allergic reaction to peanuts is anaphylaxis — a life-threatening whole-body response to an allergen. Symptoms may include impaired breathing, swelling in the throat, a sudden drop in blood pressure, pa...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-215969"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 15 Oct 2020 14:02:56 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Allergic Rhinitis - Pipeline Review, H1 2020]]></title>
      <link>https://www.leadingmarketresearch.com/allergic-rhinitis-pipeline-review-h1-2020</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Pipeline Review, H1 2020, provides an overview of the Allergic Rhinitis (Respiratory) pipeline landscape.<br><br>Allergic rhinitis is an allergic reaction that happens when immune system overreacts to substances that is inhaled. An allergen is something that triggers an allergy. When a person with allergic rhinitis breathes in an allergen such as pollen, mold, animal dander, or dust, the body releases chemicals that cause allergy symptoms. Symptoms of allergic rhinitis include stuffy runny nose, sneezing, swollen eyelids, itchy mouth, throat, ears. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Allergic Rhinitis - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Allergic Rhinitis (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-214806"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 07 May 2020 13:13:49 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Peanut Allergy - Pipeline Review, H1 2020]]></title>
      <link>https://www.leadingmarketresearch.com/peanut-allergy-pipeline-review-h1-2020</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Pipeline Review, H1 2020, provides an overview of the Peanut Allergy (Immunology) pipeline landscape.<br><br>Peanut allergy is common, especially in children. An allergic response to peanuts usually occurs within minutes after exposure, and symptoms range from mild to severe. Peanut allergy signs and symptoms can include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, digestive problems, such as diarrhea, stomach cramps, nausea or vomiting, tightening of the throat, shortness of breath or wheezing and runny nose. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Peanut Allergy - Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Peanut Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecu...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-214832"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 07 May 2020 13:13:49 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Ragweed Pollen Allergy - Pipeline Review, H2 2019]]></title>
      <link>https://www.leadingmarketresearch.com/ragweed-pollen-allergy-pipeline-review-h2-2019</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Ragweed Pollen Allergy - Pipeline Review, H2 2019, provides an overview of the Ragweed Pollen Allergy (Immunology) pipeline landscape.<br><br>Ragweed allergy occurs when ragweed pollen in the air enters the nose and throat of people who are allergic to that pollen, it can cause allergy and asthma symptoms. Symptoms include sneezing, runny or stuffy nose, itchy throat or inside of ears, hives, and swollen eyelids and itchy eyes. Treatment includes decongestant, antihistamine and nasal corticosteroid. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Ragweed Pollen Allergy - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Ragweed Pollen Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the th...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-212715"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 11 Dec 2019 11:38:48 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Allergic Rhinitis - Pipeline Review, H2 2019]]></title>
      <link>https://www.leadingmarketresearch.com/allergic-rhinitis-pipeline-review-h2-2019</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Pipeline Review, H2 2019, provides an overview of the Allergic Rhinitis (Respiratory) pipeline landscape.<br><br>Allergic rhinitis is an allergic reaction that happens when immune system overreacts to substances that is inhaled. An allergen is something that triggers an allergy. When a person with allergic rhinitis breathes in an allergen such as pollen, mold, animal dander, or dust, the body releases chemicals that cause allergy symptoms. Symptoms of allergic rhinitis include stuffy runny nose, sneezing, swollen eyelids, itchy mouth, throat, ears. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Allergic Rhinitis - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Allergic Rhinitis (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-212721"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 11 Dec 2019 11:38:48 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Cat Allergy - Pipeline Review, H2 2019]]></title>
      <link>https://www.leadingmarketresearch.com/cat-allergy-pipeline-review-h2-2019</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Cat Allergy - Pipeline Review, H2 2019, provides an overview of the Cat Allergy (Immunology) pipeline landscape.<br><br>Cat allergy is an allergic reaction to one or more allergens produced by cats. Symptoms include sneezing, runny or stuffy nose, facial pain (from nasal congestion), coughing, chest tightness, shortness of breath and wheezing, watery, red or itchy eyes and skin rash or hives. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Cat Allergy - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Cat Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.<br><br>The Cat Allergy (Immunology) p...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-212610"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 11 Dec 2019 11:13:09 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Grass Pollen Allergy - Pipeline Review, H2 2019]]></title>
      <link>https://www.leadingmarketresearch.com/grass-pollen-allergy-pipeline-review-h2-2019</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Grass Pollen Allergy - Pipeline Review, H2 2019, provides an overview of the Grass Pollen Allergy (Immunology) pipeline landscape.<br><br>Grass pollen allergy is a reaction which occurs soon after exposure to pollen from grasses. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, tightening of the throat, shortness of breath or wheezing and runny nose. Predisposing factors include age, family history and other allergies. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Grass Pollen Allergy - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Grass Pollen Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the the...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-212621"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Wed, 11 Dec 2019 11:13:09 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Birch Pollen Allergy - Pipeline Review, H1 2019]]></title>
      <link>https://www.leadingmarketresearch.com/birch-pollen-allergy-pipeline-review-h1-2019</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Birch Pollen Allergy - Pipeline Review, H1 2019, provides an overview of the Birch Pollen Allergy (Immunology) pipeline landscape.<br><br>Birch pollen allergy is a reaction which occurs soon after exposure to pollen of birch trees. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, digestive problems, such as diarrhea, stomach cramps, nausea or vomiting, tightening of the throat, shortness of breath or wheezing and runny nose. Predisposing factors include age, family history and other allergies. Treatment includes drugs belonging to class of antihistamines. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Birch Pollen Allergy - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Birch Pollen Allergy (Immunology), complete with analysis by stage of development, drug target, mec...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-208096"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 26 Mar 2019 12:29:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[House Dust Mite Allergy - Pipeline Review, H1 2019]]></title>
      <link>https://www.leadingmarketresearch.com/house-dust-mite-allergy-pipeline-review-h1-2019</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide House Dust Mite Allergy - Pipeline Review, H1 2019, provides an overview of the House Dust Mite Allergy (Immunology) pipeline landscape.<br><br>House dust mite allergy is an allergic reaction to tiny bugs that commonly live in house dust. Symptoms include frequent sneezing, a runny, stuffy, itchy nose and irritated eyes. Asthma and eczema can also be triggered by a dust mite allergy. Symptoms often worsen when the individual comes in close proximity to disturbed dust. The predisposing factors include family history and age. Treatment includes antihistamines, decongestants and corticosteroids. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide House Dust Mite Allergy - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for House Dust Mite Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-208097"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 26 Mar 2019 12:29:57 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Allergic Conjunctivitis Global Clinical Trials Review, H2, 2018]]></title>
      <link>https://www.leadingmarketresearch.com/allergic-conjunctivitis-global-clinical-trials-review-h2-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Allergic Conjunctivitis Global Clinical Trials Review, H2, 2018&quot; provides an overview of Allergic Conjunctivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic Conjunctivitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strate...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-207019"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 07 Dec 2018 15:52:59 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Allergic Rhinitis Global Clinical Trials Review, H2, 2018]]></title>
      <link>https://www.leadingmarketresearch.com/allergic-rhinitis-global-clinical-trials-review-h2-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Allergic Rhinitis Global Clinical Trials Review, H2, 2018&quot; provides an overview of Allergic Rhinitis clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic Rhinitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain compe...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-207020"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 07 Dec 2018 15:52:59 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2018]]></title>
      <link>https://www.leadingmarketresearch.com/allergic-rhino-conjunctivitis-global-clinical-trials-review-h2-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2018&quot; provides an overview of Allergic Rhino-Conjunctivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic Rhino-Conjunctivitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effect...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-207021"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 07 Dec 2018 15:52:59 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Allergies Global Clinical Trials Review, H2, 2018]]></title>
      <link>https://www.leadingmarketresearch.com/allergies-global-clinical-trials-review-h2-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Allergies Global Clinical Trials Review, H2, 2018&quot; provides an overview of Allergies clinical trials scenario. This report provides top line data relating to the clinical trials on Allergies. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.<br><br...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-207022"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 07 Dec 2018 15:52:59 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Peanut Allergy - Pipeline Review, H2 2018]]></title>
      <link>https://www.leadingmarketresearch.com/peanut-allergy-pipeline-review-h2-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Pipeline Review, H2 2018, provides an overview of the Peanut Allergy (Immunology) pipeline landscape.<br><br>Peanut allergy is common, especially in children. An allergic response to peanuts usually occurs within minutes after exposure, and symptoms range from mild to severe. Peanut allergy signs and symptoms can include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, digestive problems, such as diarrhea, stomach cramps, nausea or vomiting, tightening of the throat, shortness of breath or wheezing and runny nose. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Peanut Allergy - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Peanut Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecu...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-204897"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Thu, 29 Nov 2018 13:32:16 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Allergic Rhinitis - Pipeline Review, H1 2018]]></title>
      <link>https://www.leadingmarketresearch.com/allergic-rhinitis-pipeline-review-h1-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Pipeline Review, H1 2018, provides an overview of the Allergic Rhinitis (Respiratory) pipeline landscape.<br><br>Allergic rhinitis is an allergic reaction that happens when immune system overreacts to substances that is inhaled. An allergen is something that triggers an allergy. When a person with allergic rhinitis breathes in an allergen such as pollen, mold, animal dander, or dust, the body releases chemicals that cause allergy symptoms. Symptoms of allergic rhinitis include stuffy runny nose, sneezing, swollen eyelids, itchy mouth, throat, ears. <br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Allergic Rhinitis - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Allergic Rhinitis (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The ...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-200861"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Tue, 10 Apr 2018 12:37:44 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Allergic Asthma Global Clinical Trials Review, H1, 2017]]></title>
      <link>https://www.leadingmarketresearch.com/allergic-asthma-global-clinical-trials-review-h1-2017</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Allergic Asthma Global Clinical Trials Review, H1, 2017&quot; provides an overview of Allergic Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-198749"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 12 May 2017 15:24:23 +0000</pubDate>
    </item>
  </channel>
</rss>
